Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Kinexus Expands PhosphoNet, Biognosys LiverDig 100 Panel

Premium

Kinexus Bioinformatics has released an upgrade of its PhosphoNet database of known and predicted human phosphorylation sites.

The free resource now includes data on more than 177,000 experimentally confirmed human phosphorylation sites and 789,000 computationally predicted phosphorylation sites.


Biognosys has launched the LiverDig 100 assay panel, a multiple reaction monitoring assay that enables quantification of 100 rat liver proteins. The company said the assay panel is useful for various preclinical applications, including mode-of-action studies and screening and validation of drug toxicity biomarkers.

The company offers the panel as a service or as a product for transfer to any contract research organization equipped with triple quadrupole mass spectrometers.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.